Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 4,693
Out of 4,767 analysts
5
Total ratings
n/a
Success rate
-32.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $56.03 | +69.55% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $96.60 | +29.40% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $7.00 | +42.86% | 1 | Mar 21, 2023 | |
| AXGN Axogen | Assumes: Buy | $15 | $17.16 | -12.59% | 1 | Nov 11, 2022 | |
| EDAP EDAP TMS | Initiates: Buy | $11 | $2.33 | +372.10% | 1 | Nov 1, 2022 | |
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $56.03
Upside: +69.55%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $96.60
Upside: +29.40%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $7.00
Upside: +42.86%
Axogen
Nov 11, 2022
Assumes: Buy
Price Target: $15
Current: $17.16
Upside: -12.59%
EDAP TMS
Nov 1, 2022
Initiates: Buy
Price Target: $11
Current: $2.33
Upside: +372.10%